По вашему запросу найдено документов: 33

Страница 1 из 4

EHMTI-0384. A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL FOR NON-INVASIVE DYNAMIC TRANS-CUTANEOUS ELECTRICAL NERVES STIMULATION IN MANAGEMENT OF TENSION TYPE HEADACHES
Akhmadeeva, L., Valeeva, D., Naprienko, M., Goldobina, L., Rayanova, G., Veytsman, B. (2014)
TENS) is one of them. We designed a protocol for a randomized double blind placebo controlled clinical trial
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Lomakin, NV, Bakirov, BA, Protsenko, DN, Mazurov, VI, Musaev, GH, Moiseeva, OM, Pasechnik, ES, Popov, VV, Smolyarchuk, EA, Gordeev, IG, Gilyarov, MY, Fomina, DS, Seleznev, AI, Linkova, YN, Dokukina, EA, Eremeeva, AV, Pukhtinskaia, PS, Morozova, MA, Zinkina-Orikhan, AV, Lutckii, AA (2021)
Objective and design The aim of this double-blind, placebo-controlled, phase III CORONA clinical
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
Alexeeva, E, Horneff, G., Dvoryakovskaya, T., Denisova, R., Nikishina, I., Zholobova, E., Malievskiy, V., Santalova, G., Stadler, E., Balykova, L., Spivakovskiy, Y., Kriulin, I., Alshevskaya, A., Moskalev, A. (2021)
) or placebo+MTX (n = 33) for up to 24 weeks, followed by a 24-week open-label phase. The efficacy endpoints
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T, De Souza Viana, L., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J.G., Psyrri, A., Vasilevskaya, I., Nangia, C.S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J.M., Asarawala, N., Nicolau, U.R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E.E.W. (2019)
. Interventions: Patients were randomized (2:1) to treatment with afatinib (40 mg/d) or placebo, stratified
ПРОФИЛАКТИКА ОСТРЫХ РЕСПИРАТОРНЫХ ВИРУСНЫХ ИНФЕКЦИЙ, ВКЛЮЧАЯ ГРИПП, У ДЕТЕЙ В ПЕРИОД ПОДЪЕМА СЕЗОННОЙ ЗАБОЛЕВАЕМОСТИ: РЕЗУЛЬТАТЫ МЕЖДУНАРОДНОГО ДВОЙНОГО СЛЕПОГО ПЛАЦЕБО-КОНТРОЛИРУЕМОГО РАНДОМИЗИРОВАННОГО КЛИНИЧЕСКОГО ИССЛЕДОВАНИЯ
PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA IN CHILDREN DURING THE PEAKS OF SEASONAL MORBIDITY: THE RESULTS OF THE INTERNATIONAL DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL
Geppe, N.А., Gorelov, A.V., Shamsheva, O.V., Sitnikov, I.G., Sitnikova, E.P., Steshin, V.Yu., Melnikova, I.M., Chernaya, N.L., Votyakova, O.I., Ehgamova, I.N., Lukashova, L.V., Yakovleva, L.V., Kovalenko, T.V., Velikoretskaya, M.D., Kudryashova, M.А., ГЕППЕ НАТАЛЬЯ АНАТОЛЬЕВНА, ГОРЕЛОВ АЛЕКСАНДР ВАСИЛЬЕВИЧ, ШАМШЕВА ОЛЬГА ВАСИЛЬЕВНА, СИТНИКОВ ИВАН ГЕРМАНОВИЧ, СИТНИКОВА ЕЛЕНА ПАВЛОВНА, СТЕШИН ВАДИМ ЮРЬЕВИЧ, МЕЛЬНИКОВА ИРИНА МИХАЙЛОВНА, ЧЕРНАЯ НАТАЛИЯ ЛЕОНИДОВНА, ВОТЯКОВА ОЛЬГА ИННОКЕНТЬЕВНА, ЭГАМОВА ИНТИЗОР НОРМУХАММАДОВНА, ЛУКАШОВА ЛАРИСА ВЛАДИМИРОВНА, ЯКОВЛЕВА ЛЮДМИЛА ВИКТОРОВНА, КОВАЛЕНКО ТАТЬЯНА ВИКТОРОВНА, ВЕЛИКОРЕЦКАЯ МАРИНА ДМИТРИЕВНА, КУДРЯШОВА М.А. (2020)
OF SEASONAL MORBIDITY: THE RESULTS OF THE INTERNATIONAL DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED CLINICAL
Применение препарата, содержащего технологически обработанные антитела к каннабиноидному рецептору 1-го типа, для лечения ожирения у взрослых: результаты многоцентрового двойного слепого плацебо-контролируемого рандомизированного клинического исследования
The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical trial
Demidova, TY, Krasil'nikova, EI, Vorob'ev, SV, Morugova, TV, Adasheva, TV, Демидова, Т.Ю., Красильникова, Е.И., Воробьев, С.В., Моругова, Т.В., Адашева, Т.В. (2021)
in the treatment of obesity in adults: results of a multicenter double blind placebo controlled randomized clinical
Младенческие колики: где грань между нормой и патологией? Роль нарушения микро-биома кишечника
Infant colic: Where is the line between norm and pathology, the role of disruption of the intestinal microbiome
Panova, L.D., Панова, Л. Д. (2021)
THE LEVEL OF NATURAL AUTOANTIBODIES TO IFN-GAMMA IN VARICELLA INFECTION TREATED WITH ANTIVIRAL DRUG ANAFERON FOR CHILDREN: A PILOT STUDY
DON, E., TARASOV, S., PUTILOVSKIY, M., VAN DER MEIDE, N., EGOROV, V. (2020)
for children (AC, the API are highly diluted antibodies to IFN-γ) in comparison with placebo, and to correlate
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERY
LEGG, L.A., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M.A., DENNIS, M., MEAD, G.E., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J (2019)
(fluoxetine versus placebo under supervision) has recently been published, and it is now appropriate to update
B-CURE LASER DENTAL PRO TECHNOLOGY FOR PREVENTION AND TREATMENT OF PERI-IMPLANT MUCOSITIS
Gileva, O.S., Libik, T.V., Chuprakov, M.A., Yakov, A.Y., Mirsaeva, F.Z. (2017)
blind randomized prospective one-center comparative placebo-controlled clinical trial is carried out

Страница 1 из 4

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год